, a bio/informatics shared resource is still "open for business" - Visit the CDS website

Haydar Frangoul
Faculty Member
Last active: 3/27/2014

  1. Targeted Busulfan therapy with a steady-state concentration of 600-700‚ÄČng/mL in patients with sickle cell disease receiving HLA-identical sibling bone marrow transplant. Maheshwari S, Kassim A, Yeh RF, Domm J, Calder C, Evans M, Manes B, Bruce K, Brown V, Ho R, Frangoul H, Yang E (2014) Bone Marrow Transplant 49(3): 366-9
    › Primary publication · 24317124 (PubMed)
  2. Safety of high dose trivalent inactivated influenza vaccine in pediatric patients with acute lymphoblastic leukemia. McManus M, Frangoul H, McCullers JA, Wang L, O'Shea A, Halasa N (2014) Pediatr Blood Cancer 61(5): 815-20
    › Primary publication · 24249544 (PubMed) · PMC4310469 (PubMed Central)
  3. Cost saving associated with implementing a stepwise approach to HLA typing of related donors before hematopoietic SCT. Frangoul H, Crowe D (2014) Bone Marrow Transplant 49(6): 850-1
    › Primary publication · 24566707 (PubMed)
  4. Avascular necrosis of bone after allogeneic hematopoietic cell transplantation in children and adolescents. Li X, Brazauskas R, Wang Z, Al-Seraihy A, Baker KS, Cahn JY, Frangoul HA, Gajewski JL, Hale GA, Hsu JW, Kamble RT, Lazarus HM, Marks DI, Maziarz RT, Savani BN, Shah AJ, Shah N, Sorror ML, Wood WA, Majhail NS (2014) Biol Blood Marrow Transplant 20(4): 587-92
    › Primary publication · 24388803 (PubMed) · PMC3959243 (PubMed Central)
  5. t(17;19) in Children with Acute Lymphocytic Leukemia: A Report of 3 Cases and a Review of the Literature. Minson KA, Prasad P, Vear S, Borinstein S, Ho R, Domm J, Frangoul H (2013) Case Rep Hematol : 563291
    › Primary publication · 23346431 (PubMed) · PMC3549381 (PubMed Central)
  6. Second malignancies after autologous hematopoietic cell transplantation in children. Danner-Koptik KE, Majhail NS, Brazauskas R, Wang Z, Buchbinder D, Cahn JY, Dilley KJ, Frangoul HA, Gross TG, Hale GA, Hayashi RJ, Hijiya N, Kamble RT, Lazarus HM, Marks DI, Reddy V, Savani BN, Warwick AB, Wingard JR, Wood WA, Sorror ML, Jacobsohn DA (2013) Bone Marrow Transplant 48(3): 363-8
    › Primary publication · 22964594 (PubMed) · PMC3525761 (PubMed Central)
  7. Schimke Immunoosseous Dysplasia associated with undifferentiated carcinoma and a novel SMARCAL1 mutation in a child. Carroll C, Badu-Nkansah A, Hunley T, Baradaran-Heravi A, Cortez D, Frangoul H (2013) Pediatr Blood Cancer 60(9): E88-90
    › Primary publication · 23630135 (PubMed) · PMC3713188 (PubMed Central)
  8. Risk of subsequent malignancies in survivors of childhood leukemia. Perkins SM, Dewees T, Shinohara ET, Reddy MM, Frangoul H (2013) J Cancer Surviv 7(4): 544-50
    › Primary publication · 23749687 (PubMed)
  9. Risk adopted allogeneic hematopoietic stem cell transplantation using a reduced intensity regimen for children with thalassemia major. Hussein AA, Al-Zaben A, Ghatasheh L, Natsheh A, Hammada T, Abdel-Rahman F, Abu-Jazar H, Sharma S, Najjar R, Frangoul H (2013) Pediatr Blood Cancer 60(8): 1345-9
    › Primary publication · 23424175 (PubMed)
  10. Outcome of children who experience disease relapse following allogeneic hematopoietic SCT for hematologic malignancies. Bajwa R, Schechter T, Soni S, Gassas A, Doyle J, Sisler I, Godder K, Tatman D, Rumelhart S, Domm J, Miao Y, Frangoul H (2013) Bone Marrow Transplant 48(5): 661-5
    › Primary publication · 23128573 (PubMed)